Fore Biotherapeutics logo

Fore Biotherapeutics

A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics

46 employees · est. 2011 · Philadelphia, United States

VS
Probmet Therapeutics logo

Probmet Therapeutics

An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients.

2 employees · est. 2022 · Denmark

Fore Biotherapeutics is the older company (2011 vs 2022); Fore Biotherapeutics is the larger of the two.

Side-by-Side Comparison

Fore Biotherapeutics Probmet Therapeutics
Founded
2011 older 2022
Headquarters
Philadelphia, United States Denmark
Employees
46 larger 2
Industry
Biotechnology, Health Care Health Care, Health and Wellness
Funding Stage
Series D Convertible Note
Total Funding
$166.50M $500.00K
Funding Rounds
9 1
Services
Not tracked yet Targeted Cancer Treatments, Drug Discovery and Development, Clinical Trial Research, Biomarker Strategy
Target Customers
Not tracked yet Breast Cancer Patients with Brain Metastasis, Oncologists and Clinical Researchers, Pharmaceutical and Biotech Companies
Taxonomy
Precision Oncology, Cancer Therapies, Functional Genomics, Science, Innovation, Precision Medicine, Oncology Research, Drug Development, Cancer Treatment, Precision Medicine Company Oncology Therapeutics, Targeted Treatments, Breast Cancer, Brain Metastasis, Precision Medicine, Metastatic Cancer, Therapeutic Development, Innovation In Cancer Treatment, Breakthrough Therapies, Neuroscience Oncology, Cancer Research, Pharmaceuticals
Website
fore.bio probmet.com
Fore Biotherapeutics logo

About Fore Biotherapeutics

Fore Biotherapeutics is a biotechnology startup based in the United States, founded in 2011. The company's slogan, "A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics," reflects its dedication to developing cancer therapies guided...

Probmet Therapeutics logo

About Probmet Therapeutics

Probmet Therapeutics, headquartered in Denmark, is making strides in the field of precision oncology with a focus on developing new therapies for metastatic breast cancer in the brain. Founded in 2022, the company operates within the Health Care and Health and Wellness industries. Its core mission r...

We will tell you when either one moves

BounceWatch watches Fore Biotherapeutics and Probmet Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Fore Biotherapeutics and Probmet Therapeutics — by email.

Frequently Asked Questions

Fore Biotherapeutics — A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics. Probmet Therapeutics — An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Fore Biotherapeutics has raised $166.50M while Probmet Therapeutics has raised $500.00K.
Fore Biotherapeutics and Probmet Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Fore Biotherapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Fore Biotherapeutics on 11 Sep 2024, and Probmet Therapeutics on 14 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy